1[1]Mortea Naghavi MD,Peter Libby MD,Erling Falk MD.From vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies[J ].Part Ⅱ Circulation,2003,108:1772
2[2]Mortea Naghavi MD,Peter Libby MD,Casscells SW.From vulnerable Plaque to Vulnerable Patient[J ].Part L Circulation,2003,108(14):1664
3[3]Paul Schoenhagen MD,E Murat Tuzcu MD,Stephen G Ellis MD.Plaque Vulnerability,Plaque Rupture,and Acute Coronary Syndromes.(Multi)-Focal Manifestation of a Systemic Disease Process [ J ].Circulation,2002,106:760
4[4]Varnava AM,Mills PG,Davies MJ.Pelationship between coronary artery remodeling and plaque vulnerability[ J ].Circulation,2002,105(8):939 943
5[5]Varbava AM,Mills PG,Davies MJ.Relationship between coronary artery remodeling and qlaque vulnerability[ J ].Circulation,2002,105:939-943
7[8]Mario-Luise Breanan ph D,Marc S,Penn MD,et al.Prognostic Value of Myeloperoxidase in Patients with Chest Pain[J].N Engl J Med,2003,349(17):1595-1604
8[9]Koiwaya Y,Nagoshi T,Doi H,et al.Angiographic features at ischemia or infarct-related sites in patients with acute coronary syndrome:morphology changing in arelatively short time [ J ].J Cardiol,2001,38:187-196
9[10]Porter TR,Li S,Oster R,et al.The clinical implications of no reflow demonstrated with intravenous perfluoro carbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction[ J ].Am J Cardiol,1998,82:1173-1177
